Events

 

  • Mizuho CNS Deep Management Day
    September 19th
    The Langham Boston
    Boston, MA
  • Future Leaders in the Biotech Industry conference
    April 7th at 2:30 p.m. Eastern Time
    Millennium Broadway Hotel & Conference Center
    New York, NY
  • Alzheimer’s & Parkinson’s Diseases Congress – AD/PD™
    Translational Research in Drug Discovery for AD: a Plethora of Targets: Which is the Best, is There “a Best One”?
    March 29 – April 2, 2017
    Vienna, Austria
  • Clinical Trials in Alzheimer’s Disease (CTAD)
    CT1812, a drug candidate for Alzheimer’s disease, achieves predicted therapeutic concentrations after multiple dosing in healthy human volunteers
    December 8-10, 2016
    San Diego, CA
  • Society for Neuroscience Meeting November 2016
    • – Characterization of alpha synuclein oligomers from Parkinson’s patient tissue
    • – Identification of drug candidates that block the effects of alpha-synuclein oligomers on membrane trafficking
    • – Sigma-2/PGRMC1 antagonist pharmacodynamic target engagement biomarker discovery for Alzheimer’s disease
    • – Sigma-2/PGRMC1 antagonists as disease-modifying therapeutics for Alzheimer’s disease
    • – On the identity of sigma-2 binding sites and PGRMC1: evidence in neurons relating to Alzheimer’s disease

    November 12-16, 2016
    San Diego, CA

  • Alzheimer’s Association International Conference (AAIC) 2016
    A Two-Part, Double-Blind, Placebo-Controlled, Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of CT1812 in Healthy Volunteers
    July 24 – 28, 2016
    Toronto, Canada
  • Alzheimer’s & Parkinson’s Diseases Congress – AD/PD™
    ABeta 42 Oligomer Binding to Neuronal Sigma-2/Pgrmc1 Receptors is Displaced by Drug Candidates that Improve Cognitive Deficits
    March 18-22, 2015
    Nice, France
  • American Academy of Neurology
    An ABeta Antagonist and Antibodies to Specific Target Receptor Epitopes Displace ABeta in Alzheimer’s Patient Brain Tissue Sections
    April 26 – May 3, 2014
    Philadelphia, PA
  • Labroots BioConference Live: Neuroscience
    ABeta Oligomer Receptor Antagonists as Disease Modifying Alzheimers Therapeutics
    March 19-20, 2014
    View Webinar on YouTube

 

 Back to News